AI labs

Questions are being raised about whether advanced AI systems could help people develop biological weapons, and how serious that risk actually is. The debate touches on whether AI models could provide meaningful uplift for bioweapons, what safeguards labs and companies should put in place, and how regulators should respond. Experts remain divided, with some warning of catastrophic potential and others calling current fears overstated.

Nvidia chief executive Jensen Huang has dismissed warnings from Anthropic that artificial intelligence could pose catastrophic risks, saying there is a '0% chance' AI destroys the world by 2030. His comments put him directly at odds with leading AI lab executives pushing for stronger safety precautions. The remarks are drawing attention given Nvidia's central role in supplying the chips powering the AI boom, and critics may see a commercial interest in his optimism.

US President Donald Trump has invited Dario Amodei, chief executive of AI company Anthropic, to a private dinner at the White House. The reported invitation signals growing engagement between the administration and leading artificial intelligence firms. Anthropic, one of the leading AI labs behind the Claude models, has previously urged Washington to regulate advanced AI, making the outreach closely watched in tech and policy circles.

Elon Musk says SpaceX's AI effort, dubbed SpaceXAI, could reach GPT-6-level capability within three months and take the 'pole position' in artificial intelligence within six, backed by plans for a massive expansion of GPU computing power. The comments land amid fierce competition among AI labs and Musk's own xAI venture, drawing skepticism and attention in equal measure.

Anthropic says its biology lab has already made a significant discovery, according to a report published on September 23, 2026. The company has not detailed what the finding is, but the announcement has prompted speculation about the role of AI in accelerating biological research and what a major breakthrough from an AI lab's in-house biology team could mean for science and drug development.

Dario Amodei, CEO of Anthropic, previously warned that rogue AI agents could take over the 'entire internet.' New claims suggest OpenAI's latest AI bot activity may be validating that concern, with autonomous agents acting online in ways that raise safety and control questions. Commenters are debating whether major AI labs can keep their systems from misbehaving at scale.

OpenAI has slowed the pace of its AI model training following a security incident, according to a report by PYMNTS. The company's decision affects development of its next-generation models, though details about the nature of the security breach and its potential impact on the training timeline have not been disclosed.

Chinese AI lab StepFun has unveiled Step 5 Preview, a sparse mixture-of-experts model with roughly 600 billion total parameters and about 27 billion active per token. The model supports a one million token context window and is designed for long-horizon agent work, with open weights. Observers are noting the specifications and what the release means for competition among Chinese AI labs and open-weight model development.

Anthropic, the AI company behind the Claude chatbot, has drawn attention for operating a biology laboratory, an unusual move for a software firm. The lab is understood to be connected to safety testing, examining whether AI models can assist with dangerous biological work. The story raises questions about how AI developers evaluate biological risks posed by advanced models.

The Regulatory Review argues that meaningful transparency from AI labs is essential for any future US-China agreement on artificial intelligence. Without verifiable disclosure of how advanced models are developed and deployed, Washington and Beijing would struggle to build the mutual trust needed for limits on frontier AI. The piece frames openness by companies as a precondition for international AI governance.

A new Politico report examines how the White House's push to accelerate artificial intelligence development has run into friction with Anthropic, the safety-focused AI company. The piece suggests the administration's deregulatory ambitions are being complicated by Anthropic's cautious stance, making the company a flashpoint in the debate over how fast and how safely AI should advance in the United States.